Loris Y Hwang1, Yifei Ma, Anna-Barbara Moscicki. 1. Department of Pediatrics, Division of Adolescent and Young Adult Medicine, UCSF Benioff Children's Hospital, University of California, San Francisco, San Francisco, California.
Abstract
OBJECTIVE: To identify biological and behavioral risks for incident Chlamydia trachomatis among a prospective cohort of young women followed frequently. METHODS: Our cohort of 629 women from two outpatient sites was seen every 4 months (October 2000 through April 2012) for behavioral interviews and infection testing. C trachomatis was tested annually and any time patients reported symptoms or possible exposure using commercial nucleic acid amplification tests. Analyses excluded baseline prevalent C trachomatis infections. Risk factors for incident C trachomatis were assessed using Cox proportional hazards models. Significant risks (P<.10) from bivariate models were entered in a multivariate model adjusted for four covariates chosen a priori (age, race or ethnicity, condom use, study site). Backward stepwise elimination produced a final parsimonious model retaining significant variables (P<.05) and the four adjustment variables. RESULTS: The 629 women attended 9,594 total visits. Median follow-up time was 6.9 years (interquartile range 3.2-9.8), during which 97 (15%) women had incident C trachomatis. In the final multivariate model, incident C trachomatis was independently associated with human papillomavirus at the preceding visit (P<.01), smoking (P=.02), and weekly use of substances besides alcohol and marijuana (P<.01) since the prior visit. Among 207 women with available colpophotographs (1,742 visits), cervical ectopy was not a significant risk factor (P range=.16-.39 for ectopy as continuous and ordinal variables). CONCLUSION: Novel risks for C trachomatis include preceding human papillomavirus, smoking, and substance use, which may reflect both biological and behavioral mechanisms of risk such as immune modulation, higher-risk sexual networks, or both. Improved understanding of the biological bases for C trachomatis risk would inform our strategies for C trachomatis control.
OBJECTIVE: To identify biological and behavioral risks for incident Chlamydia trachomatis among a prospective cohort of young women followed frequently. METHODS: Our cohort of 629 women from two outpatient sites was seen every 4 months (October 2000 through April 2012) for behavioral interviews and infection testing. C trachomatis was tested annually and any time patients reported symptoms or possible exposure using commercial nucleic acid amplification tests. Analyses excluded baseline prevalent C trachomatis infections. Risk factors for incident C trachomatis were assessed using Cox proportional hazards models. Significant risks (P<.10) from bivariate models were entered in a multivariate model adjusted for four covariates chosen a priori (age, race or ethnicity, condom use, study site). Backward stepwise elimination produced a final parsimonious model retaining significant variables (P<.05) and the four adjustment variables. RESULTS: The 629 women attended 9,594 total visits. Median follow-up time was 6.9 years (interquartile range 3.2-9.8), during which 97 (15%) women had incident C trachomatis. In the final multivariate model, incident C trachomatis was independently associated with human papillomavirus at the preceding visit (P<.01), smoking (P=.02), and weekly use of substances besides alcohol and marijuana (P<.01) since the prior visit. Among 207 women with available colpophotographs (1,742 visits), cervical ectopy was not a significant risk factor (P range=.16-.39 for ectopy as continuous and ordinal variables). CONCLUSION: Novel risks for C trachomatis include preceding human papillomavirus, smoking, and substance use, which may reflect both biological and behavioral mechanisms of risk such as immune modulation, higher-risk sexual networks, or both. Improved understanding of the biological bases for C trachomatis risk would inform our strategies for C trachomatis control.
Authors: Sami L Gottlieb; Robert C Brunham; Gerald I Byrne; David H Martin; Fujie Xu; Stuart M Berman Journal: J Infect Dis Date: 2010-06-15 Impact factor: 5.226
Authors: Ibrahim I Daud; Mark E Scott; Yifei Ma; Stephen Shiboski; Sepideh Farhat; Anna-Barbara Moscicki Journal: Int J Cancer Date: 2011-02-15 Impact factor: 7.396
Authors: Finn Egil Skjeldestad; Mark A Marsico; Heather L Sings; Svein Arne Nordbø; Gunnar Størvold Journal: Sex Transm Dis Date: 2009-05 Impact factor: 2.830
Authors: Jennifer Walker; Sepehr N Tabrizi; Christopher K Fairley; Marcus Y Chen; Catriona S Bradshaw; Jimmy Twin; Nicole Taylor; Basil Donovan; John M Kaldor; Kathleen McNamee; Eve Urban; Sandra Walker; Marian Currie; Hudson Birden; Francis Bowden; Jane Gunn; Marie Pirotta; Lyle Gurrin; Veerakathy Harindra; Suzanne M Garland; Jane S Hocking Journal: PLoS One Date: 2012-05-25 Impact factor: 3.240
Authors: William M Geisler; Jane S Hocking; Toni Darville; Byron E Batteiger; Robert C Brunham Journal: Clin Infect Dis Date: 2022-04-13 Impact factor: 9.079
Authors: Ali N Russell; Xiaojing Zheng; Catherine M O'Connell; Brandie D Taylor; Harold C Wiesenfeld; Sharon L Hillier; Wujuan Zhong; Toni Darville Journal: J Infect Dis Date: 2015-09-07 Impact factor: 5.226
Authors: Carina King; Gwenda Hughes; Martina Furegato; Hamish Mohammed; John Were; Andrew Copas; Richard Gilson; Maryam Shahmanesh; Catherine H Mercer Journal: EClinicalMedicine Date: 2018-11-28
Authors: Inga Veličko; Alexander Ploner; Pär Sparén; Lena Marions; Björn Herrmann; Sharon Kühlmann-Berenzon Journal: BMJ Open Date: 2016-08-26 Impact factor: 2.692